In antibiotic-producing organisms the role of plasmids in production1) of and resistance2) to antibiotics has recently been demonstrated. Bacillus circulans strain NRRL B-33123) is used for the industrial production of butirosin, an aminoglycoside closely related to neomycin4). This strain also produces an enzyme (APH) which phosphorylates the 3'-hydroxyl group of butirosin and structurally-related compounds5~7).
Tests for Antibiotic Susceptibility Disk agar diffusion susceptibility tests12) were done on MUELLER-HINTON agar medium.
Assay for Aminoglycoside-modifying Enzymes. The bacterial extracts were prepared7) and the enzymes assayed by the phosphocellulose paper binding technique13) as described.
Preparation of DNA Plasmid DNA from B. circulans was purified by a technique already described14) and modified as follows. Cells from 200 ml of an exponential phase culture were harvested and resuspended in 20 ml of SET buffer (0.15 M NaCl, 0.1 M EDTA, 0.05 M tris-HCl (pH 8.0)) containing lysozyme (1 mg/ml) and ribonuclease A (500 i4g/ml). This suspension was divided into 1 ml aliquots and incubated at 37°C for l hour. The resulting protoplasts were lysed with 0.2% N-lauroyl sarcosine. The DNA was sheared by passing the lysates five times through a 2-ml syringe, pooled, adjusted to 33 g with SET buffer, and mixed with 31 g of cesium chloride. Ethidium bromide was added to a final concentration of 150 /4g/ml. The solution was centrifuged at 18°C for 19 hours at 50,000 rpm in a Beckman VTi-50 rotor. Fractions containing plasmid DNA were pooled and banded a second time at 18°C for 8 hours at 65,000 rpm in a Beckman VTi-65 rotor. Fractions containing DNA were pooled and ethidium bromide was removed by four consecutive extractions with iso-propanol. The DNA was dialyzed four times against 1 liter of 10 mM tris-HCl, I mM EDTA (pH 7.5), and stored at 4°C.
The following DNAs were prepared according to the procedures described previously: RP4 plasmid15), ColE1 factor and derivative plasmids16), bacteriophage 2cI85717), and B. circulans7).
Agarose Gel Electrophoresis of Restriction Endonuclease Digests DNA was digested with restriction endonuclease EcoRI in reaction mixtures of 70 14 for analytical purposes or of 350 ,ul for preparative gels, containing 100 mM tris-HCl (pH 7.8) and 100 mM MgCl2. The reactions were allowed to proceed for 1 hour at 37°C, then heated at 68°C for 10 minutes and chilled at 0°C. The resulting DNA fragments were separated by electrophoresis in horizontal slab gels containing 0.7% or 0.8% agarose. Electrophoresis and staining were as described18). Hybridization 32P-Labeled complementary RNA (cRNA) synthesized in reaction mixtures containing plasmid DNA, E. coli K12 RNA polymerase, GTP, CTP, UTP, and [a-32P]ATP was separated from non incorporated radioactive material by passage through a column of Sephadex G-50 as described previously17). Restriction endonuclease generated DNA fragments fractionated by agarose gel electrophoresis were transferred to cellulose nitrate sheets (Sartorius) as described by SOUTHERN19). Hybridization of cRNA probes to the DNA immobilized on the membrane filters was as described by DENHARDT20). Hybridization was revealed by autoradiography using XRI-Omat Kodak films.
Testing for Resistance
Resistance of B. circulans strain NRRL B-3312 to butirosin and ribostamycin and susceptibility to other aminoglycoside antibiotics7) was tested by the disk agar diffusion method12). The synthesis, by this strain, of an arninoglycoside 3'-phosphotransferase was monitored by phosphocellulose paper binding assays13).
Results

Plasmid Content of B. circulans NRRL B-3312
Strain B-3312 was shown by uItrace ntrifugation in cesium chloride -ethidium bromide to contain covalently closed circular DNA.
The electrophoretic mobility of the purified plasmid DNA in agarose gel is shown in Fig. 1 .
Strain B-3312 was found to harbor a plasmid which was designated pIP850. It had a molecular size of approximately 48 kilobases (kb) and five EcoRI-generated DNA fragments which were numbered in order of decreasing size. Two to three jig of plasmid DNA were digested with EcoRl.
Fragments obtained by digestion of I, c1857 DNA, 48 kb31) with EcoRI32) and by digestion of RP4, 54 kb9), ColE1::Tn3 (RSF2124), 11.6 kb10) and ColE1, 6.56 kb11) with EcoRl were used as molecular size standards.
Electrophoresis was carried out in a 0.8 % agarose horizontal slab gel (18 x 13 x 0.4 cm) for 14 hours at 3 V/cm. The molecular size of the DNA fragments is expressed in kilobases. The values are means from four determinations in 0.7 or 0.8 % agarose. Fig. 2 . Analysis of DNA by hybridization. Five jig of the plasmid DNAs or 10Jirg of B. circulans total DNA as indicated on the bottom line (drivers) were digested with EcoRl restriction endonuclease. The resulting DNA fragments were fractionated by electrophoresis through horizontal slab gels (0.7 % agarose, 18 x 13 x 0.4 cm) for 14 hours at 3 V/cm, transferred to nitrocellulose sheets and hybridized to in vitro 3=P-labeled cRNA of plasmid pAT6 or pIP850 as indicated on the top line (probes). The autoradiograms were exposed for a period of 12 hours. the five EcoRI-generated fragments of B. circulans total DNA. These fragments had migration properties similar to those of pIP850.
The probe made from pAT6 did not hybridize to plasmid pIP850 DNA. The reciprocal experiment (i.e., pIP850 cRNA versus pAT6 DNA) was also negative. These results are consistent with that of the agarose gel electrophoresis indicating that the insert in pAT6 is different from every EcoRI DNA fragment of plasmid pIP850.
Discussion
It has been proposed that antibiotic-producing organisms might represent the source of R determinants for clinical isolates of pathogenic bacteria 22.23). This suggestion relies on two kinds of evidence: many antibiotic-producing organisms code for biochemical mechanisms that are similar to those that determine antibiotic resistance in plasmid containing bacteria22~29) and the gene encoding APH (3') activity from B. circulans confers to the unrelated bacterium E. coli an aminoglycoside resistance phenotype similar to that encoded by "natural" R plasmids7).
This working hypothesis implies intergeneric transfer of genetic information from antibiotic-producing organisms ultimately to pathogenic clinical isolates. Although it is not a prerequisite, the location of the structural gene for the 3'-phosphotransferase already on a plasmid in the butirosin-producing strain of B. circulans would constitute additional indirect evidence for the notion that clinical resistance to antibiotics determined by R plasmids originates in antibiotic-producing organisms.
We have detected a plasmid, pIP850, in B. circulans strain NRRL B-3312 and demonstrated that it does not carry the gene for the aminoglycoside-modifying activity. The role of this plasmid remains unknown; it may be involved in the synthesis, regulation of production, or resistance to butirosin.
The B. circulans 3'-phosphotransferase determines low-level resistance to butirosin and ribostamycin when present in its original host and high-level resistance to a much wider range of aminoglycosides when present in E. coli7). This observed difference is probably due to a gene dosage effect. The gene for the phosphotransferase is associated with a relaxed replicating plasmid in E. coli and is unlikely to be present in multicopy in B. circulans: the probe made from pAT6 hybridized to a single EcoRl-generated fragment of B. circulans total DNA and a low molecular weight multicopy plasmid would have been readily detected by our technique14). Gene dosage effect has already been reported in E. coli for the same type of enzyme originating in Staphylococcus aureus17).
Of course, we cannot rule out the possibility that the structural gene for the phosphotransferase is located on a large, low copy, plasmid which could have escaped the technique used in this study. This is indeed a possibility especially since DAVIES (personal communication) and DOWDING30) have also detected extrachromosomal DNA in this B. circulans strain using different techniques. It would be of interest to compare the three covalently closed circular DNAs independently obtained. 
